SOURCES SOUGHT
A -- NIH Tetramer Core Facility
- Notice Date
- 11/16/2011
- Notice Type
- Sources Sought
- NAICS
- 541711
— Research and Development in Biotechnology
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Office of Acquisitions, 6700 B Rockledge Room 3214 MSC7612, Bethesda, Maryland, 20892-7612
- ZIP Code
- 20892-7612
- Solicitation Number
- HHS-NIH-NIAID(AI)-SBSS-11-132
- Archive Date
- 12/15/2011
- Point of Contact
- Tom Bahrami, Phone: 3014512654, Liem T. Nguyen, Phone: 301-496-0612
- E-Mail Address
-
bahramit@niaid.nih.gov, lnguyen@niaid.nih.gov
(bahramit@niaid.nih.gov, lnguyen@niaid.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- This is a Small Business Sources Sought notice for a Research and Development (R&D) requirement. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding: (1) the availability and capability of qualified small business sources; (2) whether they are small businesses; HUBZone small businesses; service-disabled, veteran-owned small businesses; 8(a) small businesses; veteran-owned small businesses; woman-owned small businesses; or small disadvantaged businesses; and (3) their size classification relative to the North American Industry Classification System (NAICS) code for the proposed acquisition. Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible. An organization that is not considered a small business under the applicable NAICS code should not submit a response to this notice. A determination by the Government not to compete this requirement as a set-aside based upon responses to this Notice is solely within the discretion of the Government. Interested parties are expected to review this notice to familiarize yourself with the requirements of this project; failure to do so will be at your firm's own risk. Description: As a part of the research program to improve our understanding of the progression, prevention, and treatment of infectious and immune-mediated diseases, the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health is competing the continuing requirement for the NIH Major Histocompatibility Complex (MHC) Tetramer Core Facility contract (herein referred to as the NIH Tetramer Core Facility). This facility provides synthesis and distribution of soluble MHC tetramer reagents to the global research community. The scope of activities to be carried out by the NIH Tetramer Core Facility Contractor are: synthesis and distribution of soluble MHC-peptide tetramer and related reagents to the global research community; and performance of research and development to improve tetramer technologies and increase the types of products available to the biomedical research community. Such reagents include, but are not limited to: mouse, non-human primate, human, and other mammalian MHC class I monomers and tetramers; custom and pre-made mouse, non-human primate, human, and other mammalian class II tetramers; non-classical MHC TL, Qa-1, and mammalian CD1 monomers and tetramers; CD1d and other MHC ligands; and fluorophores for tetramer detection. The major functions to be carried out by the contractor are: A. Provide a tetramer production facility B. Provide a distribution, tracking, and reporting system of reagents produced C. Design a NIH Tetramer Core Facility website and provide related maintenance D. Conduct tetramer technology research and development E. Provide Tetramer Core Facility program management It is estimated that 10.8 FTEs are required to conduct these functions. While the NIH Tetramer Core Facility is responsible for providing ligands (peptidic and non-peptidic) for all pre-made reagents (where required), the NIH Tetramer Core Facility is NOT responsible for supplying ligands for custom MHC Class I and II monomer and tetramer production. Ligands for custom monomer/tetramer synthesis will be provided by the approved requestors, where required. Potential sources must demonstrate and document the following in their capability statements: Capability statements submitted as a result of this announcement should demonstrate the offerors' qualifications and experience, specifically providing evidence as to their capability to perform this requirement, with particular attention to the following: Personnel/Management: adequacy, appropriateness and relevance of expertise, experience, qualifications, and availability of the key professional and technical staff with a project of similar size, scope, and complexity. Past Performance: Past performance is considered essential. In addition to demonstrating that they have met the above qualifications, interested parties must identify at least three other projects of similar size and complexity. All capable small business organizations are encouraged to submit capability statements based on this announcement. Interested organizations should submit two copies of their capability statement addressing each of the areas cited above. Any proprietary information should be so marked. Written capability statements should be received by the Contracting Officer by November 30, 2011 by 3:00pm Eastern. Please reference the solicitation number on all related correspondence. No collect calls will be accepted. Facsimile and e-mail transmissions will be accepted. Any proprietary information should be so marked
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIAID/HHS-NIH-NIAID(AI)-SBSS-11-132/listing.html)
- Record
- SN02624380-W 20111118/111116234358-79ffb37c29468c3f314a01cab6c54631 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |